ISSN: 2640-8031
Ann Psychiatry Treatm
Review Article       Open Access      Peer-Reviewed

Opioid Crisis

Simrat Kaur Sarai1 and Steven Lippmann2*

1Research Scholar, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, USA
2Emeritus Professor, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, USA
*Corresponding author: Steven Lippmann, M.D, 401 East Chestnut Street, Suite 610, University of Louisville Clinic, Louisville, KY 40202, USA, Tel: 502-681-6788; E-mail: steven.lippmann@louisville.edu
Received: 30 December, 2017 | Accepted: 01 April, 2017 | Published: 03 April, 2017

Cite this as

Sarai SK, Lippmann S (2017) Opioid Crisis. Ann Psychiatry Treatm 2(1): 008-012. DOI: 10.17352/apt.000005

Deaths from opioid overdose in the United States doubled between 2000-2014. An increase in prescription opioid drug-induced fatalities parallels a rise in the frequency of these medications being prescribed. Although the number of legal narcotics sold in this country has nearly quadrupled, there is no change reported in the degree of pain Americans experience. Deaths are most common among those opioid users who are drug dependent, even though overdoses occur in medical and non-medical narcotic users who are not addicted.

Public health efforts have focused on providing patients with chronic pain appropriate access to opioid pain relievers, while reducing non-medical usage. However, that alone has been insufficient to curb opioid overdoses. There remains a high opioid-related morbidity and mortality among people with pain, even for those receiving these analgesics for legitimate clinical reasons. Research results demonstrating the safety and efficacy of narcotics for chronic, non-cancer pain are not evident. Surveys of patients prescribed opioids over the long-term indicate that most of them continued to experience significant distress; yet, some of them, also experience greater comfort and were without abuse of medication.

Physicians should avoid unnecessary opioid prescribing for some people with chronic conditions, although it is difficult to predict which patients might be vulnerable to addiction versus who might benefit from these pharmaceuticals. Because of such uncertainty, it is helpful when doctors screen personal and family histories for substance abuse and provide careful, regular monitoring. Strategies for reducing abuse of prescription analgesic drugs focus on physician prescribing regulations that are thus far not consistently effective.

Introduction

Over the past 25 years, doctors have been increasingly prescribing opioid drugs to people for chronic pain [1]. Fatalities due to unintentional opioid poisoning in the United States (US) are second in death only to automobile collisions [2]. In the last decade, a public health concern focused on a substantial increase in accidental prescription opioid drug-induced deaths, which parallels a rise in the frequency of these medications being prescribed [2].

Over 30 million people abuse opioids worldwide; about two million in the US evidenced substance use disorders related to prescription opioid pain relievers (OPR) during 2012 [3]. Over nine million Americans consume opioids for long-term pain control [4]. Approximately 467,000 are addicted to heroin [5]. During 2012, there were about 259 million prescriptions filled for opioid medications, a quadrupling since 1999 [6].

About 100 million Americans suffer from chronic pain and many ingest opioids for relief. OPRs are helpful in the short-term; however, their effectiveness often diminishes over time and physical dependence emerges [7]. The per-capita ingestion of oxycodone in the United States is the highest in the world, almost twice as much as in Canada and between 5-10 times the rates of some similar other countries [8]. Although the number of prescription opioids recently sold has nearly quadrupled, there is no change reported in the degree of pain Americans experience [9-12].

Between 2000-2014, deaths from opioid overdose reportedly doubled, from six to about 15 per 100,000 persons [13]. Approximately 61% of the 47,055 fatalities from all drugs specifically involved an opioid. The age-adjusted rate increased significantly from 2000-2014, up 14% during 2013-2014 [13]. The economic costs were over $55 billion [14]. More people than ever died from overdoses in 2014; the majority of these deaths involved an opioid, nearly half a million between 2000-2014 [9,13]. These overdoses kill about 78 Americans daily [9]. Approximately 82% of these fatalities are induced by prescription opioids, of which 92% are unintentional heroin overdoses; the remainder are attributed predominantly to suicide or “undetermined intent” [15]. Overdose prevention is a major public health concern [16].

While fentanyl and tramadol accounted for the largest rise in drug overdose death rates, for methadone such frequencies doubled to nearly two per 100,000 [13]. Death by heroin overdose rose by 26% and tripled since 2010 to over three per 100,000 in 2014.13 Natural or semisynthetic opioids like morphine, oxycodone, and hydrocodone were involved in fatalities at almost four per 100,000, the highest among all opioids, with a 9% increase during 2013 [17,18].

Data comparing buprenorphine versus methadone in tapered doses for managing opioid withdrawal remains limited, but data suggests that buprenorphine and methadone have similar capacity to ameliorate opioid withdrawal, without significant adverse effects [19]. Opioid dependence is a chronic disorder requiring long-term treatment. Effective options for management include pharmaceutical agents (e.g., methadone, buprenorphine and/or naltrexone) and psychosocial interventions. However, relapse rates following cessation of treatment are high, with only an estimated 25% of heroin-dependent individuals remaining abstinent after receiving methadone treatment [19]. Relapse following non-compliance with oral naltrexone is a particular concern. Episodes of opioid abuse during non-compliance have been associated with relapse to opioid dependence [20].

Emergency department contacts and substance-abuse treatment admissions related to prescription opioids have increased significantly, along with a substantial rise in healthcare costs [15].Besides overdose mortality, other adverse outcomes include emergencies due to non-medical opioid pain reliever use and neonatal abstinence syndromes. From 1997-2011, there was a nine fold increase in the number of individuals seeking treatment for addiction to these pain relievers [16].

Orthopedists were more likely than primary care physicians to write prescriptions for patients with Medicaid for chronic non-cancer pain. Prescribing such medication is an individualize transaction involving many different clinical parameters for each patient and/or doctor [21]. Emergency physicians provide narcotic analgesics three times more than their colleagues and are documented to have more opioid dependent patients. This suggests that receiving an opioid for even one encounter could increase future long-term opioid abuse and potentially increase adverse outcomes among elderly people. It is not known whether over-prescribing by some practitioners is amenable to intervention [22].

Emergency room contacts are frequent among opioid users, but only a minority of the visits were associated with back pain [23].Nonetheless, more than half of these patients received a prescription for an opioid. They were also high utilizers of all clinic services, and co-morbidity with mental health concerns was also noted. As with clinic visits, the probability of hospitalization was associated with opioid abuse, with a nearly four-fold greater chance of being hospitalized, even after adjusting for age, gender, co-morbidity, and sedative-hypnotic use. A minority of these patients are monitored in a pain clinic; most of them are managed in primary care or emergency departments. This was true even though access to pain clinic services were easily available [23].

Use

Although opioid overdoses occur in medical and non-medical opioid users who are not addicted, deaths are most common among those who are drug dependent. Recognizing non-medical abuse, enhances efforts to address this crisis by preventing or treating addiction. Although increased opioid consumption over the past two decades is largely ambulatory, prescribing for chronic, non-cancer pain and acute pain among hospitalized patients has also risen. In 2009-2010, physicians prescribed opioids to over 50% of non-surgical hospitalized patients [16,24].

Twenty-five million people in the US initiated non-medical pain reliever usage between 2002-2011 [25]. Over 5% of the population 12 years or older utilized opioid pain medication non-medically [26]. The incidence of non-medical use increased in the 1990s and peaked in 2002, with nearly three million new non-medical applications. Since 2002, non-medical utilization has declined; yet, overdose deaths, admissions for addiction treatment, and other similar events have risen dramatically [25]. Prescription pain drugs are taken by about 14% of pregnant women and resulted in a 300% rise in neonatal abstinence syndrome occurrence [27,28].

Public health efforts have focused on preserving access to OPRs for chronic pain patients, while reducing non-medical usage, but that alone was not sufficient to curb overdose frequencies. Non-medical usage includes that without a prescription and applications other than as prescribed or for an induced emotional experience. There remains a high opioid-related morbidity and mortality among people with pain, even when receiving these medications for legitimate purposes [16].

Age

Overdose deaths occur most often among adults aged 45–54. Those 55-64, evidence the greatest increase in overdose mortality, despite opioid abuse being most common among people between the ages of 15-24 [16].

Middle-aged women and elderly adults are more likely than others to experience pain complaints. Iatrogenic opioid addiction may explain why they have the largest increase in drug-induced hospitalizations. Over the past decade, Caucasian women, ages 55–64, have the biggest escalation in fatalities [16]. The National Institute on Drug Abuse has documented a decline of illegal street drug use by youths and recognized an alarming rise in their abuse of prescription opioids. In 2005, a survey of 12th graders, revealed non-medical usage of hydrocodone at over 9% and about 5% taking oxycodone [29].

Heroin

Most lethal overdoses involve prescription opioids, and heroin is related to these medicines since many users become addicted to OPRs before switching to other drugs. The National Survey on Drug Use and Health reports that 80% of heroin users say that their opioid utilization began with prescription pharmaceuticals, but then switched to heroin since it is cheaper [5].Thus, opioid addiction is associated with rises in heroin-related morbidity and mortality. Heroin addiction treatment admissions for Caucasians aged 20–34 years have risen since 2001, and overdose deaths among those at ages 18–44 rose 171% [5,16,17]. Surprisingly, the fatality rate associated with heroin is inversely related to opioid drug prescribing; these deaths increased between 2002-2006, plateaued in 2006-2008, and decreased during 2009-2013 [30]. There is a positive relationship between non-medical opioid use and the people choosing to use heroin [31].

Suicide

The prevalence of suicide attempts among opioid addicts is between 8%-17% [27,32]. Suicide is often underestimated; yet, 23% of opioid addicts in a detoxification unit and 28% of those maintained on codeine have attempted suicide.

Veterans

About 60% of veterans deployed in the Middle East and 50% of the older ones complain of chronic pain [33]. Veterans are twice as likely to die from accidental opioid overdoses as civilians. Untreated pain escalates the risk of suicide and poorly managed OPR regimens can also be dangerous. During 2010-2015, the number of veterans with opioid-use disorders grew, spiking to 55%. Approximately 13% of veterans, or 68,000, utilize opioids [17,33,34].

Causes

The National Survey on Drug Use and Health, reports abuse of prescription pain medicine is widespread and not concentrated in urban areas. The cause of this distribution is unclear, but prescription drug monitoring programs are not influencing these trends. Most subjects surveyed denied obtaining prescriptions from physicians; roughly 60% said they got their medications from friends or family [29].

Theft from pharmaceutical distribution chains such as hospitals or pharmacies are a source of drug diversion. In 2003, millions of doses of the opioid analgesics like fentanyl, hydromorphone, meperidine, methadone, morphine, and oxycodone were reported stolen, including several million of hydrocodone [29]. Stealing and/or sharing the prescription medicines of friends and relatives or obtaining multiple prescriptions from different doctors is a large source of prescription abuse; however, the relative contributions from these sources is not clear [29].

An often unreported aspect of the opioid crisis is the involvement of the pharmaceutical companies. The manufacturers have a substantial role in augmenting opioid prescribing; this might occur by influencing medical education through encouraging physicians to prescribe these drugs for patients in pain, while downplaying the dangers. Even people who have overdosed on opioids have an easy time obtaining new prescriptions, even sometimes from the same doctor. Most persons who regularly take these analgesics are physically dependent. Efforts to stop the drugs or reduce the dosage precipitates opioid withdrawal. The patients may not recognize the withdrawal, but they know these symptoms are alleviated by resumption of opioids. Consequently, they believe they need these medications to function and that facilitates even minimally effective drugs to become self-perpetuating. For many chronic pain patients, opioids do not relieve pain, but they are required to avoid narcotic withdrawal [35-37].

Although analgesic abuse is a public health crisis, the news media often frame the problem as a criminal justice issue. Between 1998-2012, some reports about opioids cite illicit drug dealing by physicians, patients, and others. Most opioid abusers were involved in criminal activity [38]. Frequently reported causes of this were illegal drug dealing and the most common solutions were law enforcement actions. Prevention-oriented approaches, such as prescription drug-monitoring programs, are suggested, but less than 5% noted expanding substance abuse treatment. Even fewer recommended medication-assisted treatments, such as buprenorphine [38,39].

Adversity

When sold illegally, the cost of opioids escalates multiple times over that at a pharmacy. Opioid abuse negatively effects patients and their family. Many addicts are not able to function well in society and may neglect important aspects of their lives, like child care. While the most severe adverse effects of opioids such as addiction, overdose, and death are stressed, some lesser consequences like constipation may not be [38].

Conclusion

While opioids are studied in short-term research, few chronic pain subjects are enrolled in longer-term trials because it is not practical to require prolonged placebo trials. Although there are a range of other drugs for pain control, such as non-steroidal anti-inflammatory agents, few investigations reveal comparative effectiveness nor evidence benefits of long-term opioid use [4].

Long-term research demonstrating the safety and efficacy of opioid pain relievers for chronic, non-cancer pain have not been documented. Surveys of patients with such issues receiving long-term opioid pain relievers indicate that most of them continued to experience significant discomfort and dysfunction. Clinicians should use caution and avoid unnecessary prescribing of OPRs for patients with various chronic conditions [16].

Many individuals on high-dose opioids, incur an increased risk for death. No investigation has evidenced high-dosages to be beneficial over the long-term. Approximately 4% of men and 2% of women on high-dose opioids (defined as >200 mg of morphine or equivalent per day) have died of opioid-related causes [38].

Nearly 10% of the general population will develop an addictive disorder in their lifetime, most often to alcohol. It is difficult for physicians to predict which patients might be vulnerable. Because of this uncertainty, doctors ought to screen for personal or family histories of substance abuse and provide monitoring on a regular basis. It is important to intervene if there are concerns and to minimize abuse or diversion [29]. Everyone should know about the abuse potential of these medications, and about how to avoid such problems. Tactics for reducing abuse of prescription analgesics focus on physician regulations and prescription monitoring; however, such practices are not always effective [29]. It remains unclear as to which patients would benefit from opioid prescribing. Further research about indications for developing dependence or addiction are needed [33,38]. The medical profession, society, and governmental agencies are concerned about opioid abuse. Treatment options are expanding and include pharmaceutical and non-pharmaceutical therapies. Regulations about prescribing and distributing such medications are tightening and remain an area of continued concern.

It is important to ensure that people who need pain relief continue to have access; doctors should be sure that patients receive these drugs when indicated. They also must be vigilant about abuse potential [29]. The American Pain Society and the American Academy of Pain Medicine have convened a panel to create a pain-control protocol to improve the safe management of chronic, non-cancer pain [29,40].

Physicians should monitor for signs of drug abuse or aberrant behavior and for evidence about the quality of patient lifestyle. Assess the level of function at the start of treatment, establish goals for the activities that pain alleviation will allow, and closely schedule regular follow-up appointments [29].

  1. Dhalla IA, Persaud N, Juurlink DN (2011) Facing up to the prescription opioid crisis. British Medical Journal 343: d5729. Link: https://goo.gl/9Eyr1n
  2. Bowman S, Eiserman J, Beletsky L, Stancliff S, Bruce RD (2013) Reducing the health consequences of opioid addiction in primary care. The American Journal of Medicine 126: 565-571. Link: https://goo.gl/9HBVG3
  3. World Drug Report (2012) United States Office on Drugs and Crime 2012. United Nations publication 1-127. Link: https://goo.gl/pYVWcC
  4. Time Magazine Releases Cover Story on Pain Killers (2015) National Pain Report. Link: https://goo.gl/KXz6nT
  5. Volkow ND (2014) America’s Addiction to Opioids: Heroin and Prescription Drug Abuse. National Institute on Drug Abuse. Link: https://goo.gl/dYyTFE
  6. Opioid Painkiller Prescribing (2014) Centers for Disease Control and Prevention 1-4. Link: https://goo.gl/O10Q2N
  7. Dzau VJ, Pizzo PA (2014) Relieving pain in America: Insights from an Institute of Medicine Committee. The Journal of American Medical Association 312: 1507-1508. Link: https://goo.gl/ksq3LT
  8. International Narcotics Control Board (2015) World Health Organization. Population data by: Pain & Policy Studies Group, University of Wisconsin/WHO Collaborating Center 1-2. Link: https://goo.gl/fhNmC2
  9. Drug overdose deaths in the United States hit record numbers in 2014 (2014) Understanding the Epidemic. Injury Prevention & Control: Opioid Overdose. Centers for Disease Control and Prevention. Link: https://goo.gl/KFmP7o
  10. Chang HY, Daubresse M, Kruszewski SP, Alexander GC (2014) Prevalence and treatment of pain in EDs in the United States, 2000 to 2010. The American Journal of Emergency Medicine 32: 421-431. Link: https://goo.gl/3iJ8Oy
  11. Daubresse M, Chang HY, Yu Y, Viswanathan S, Shah ND, et al. (2013) Ambulatory diagnosis and treatment of non-malignant pain in the United States, 2000–2010. Medical Care 51: 870-878. Link: https://goo.gl/q4unEC
  12. Prescription Opioid Overdose Data (2016) Understanding the Epidemic. Injury Prevention & Control: Opioid Overdose. Centers for Disease Control and Prevention. Link: https://goo.gl/URBHqw
  13. Rudd RA, Aleshire N, Zibbell JE, Gladden MR (2016) Increases in Drug and Opioid Overdose Deaths - United States, 2000–2014. Morbidity and Mortality Weekly Report. Centers for Disease Control and Prevention 64: 1378-1382. Link: https://goo.gl/QF51fB
  14. Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL (2011) Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Medicine 12: 657-667. Link: https://goo.gl/DqJoAM
  15. Volkow ND, Frieden TR, Hyde PS, Cha SS (2014) Medication-assisted therapies—tackling the opioid-overdose epidemic. New England Journal of Medicine 370: 2063-2066. Link: https://goo.gl/8I9XQr
  16. Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, et al. (2015) The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annual Review of Public Health 36: 559-574. Link: https://goo.gl/DsFvC9
  17. Russ RA, Aleshire N, Zibbell JE, Gladden RM (2016) Increases in drug and opioid overdose deaths–United States, 2000-2014. MMWR Morb Mortal Wkly Rep 64: 1-5. Link: https://goo.gl/2Ock67
  18. Drug Poisoning Mortality United States, 1999-2014 (2016) National Center for Health Statistics. Centers for Disease Control and Prevention. Link: https://goo.gl/PM65Hq
  19. Gowing L, Ali R, White J (2006) Buprenorphine for the management of opioid withdrawal. The Cochrane database of systematic reviews 19: CD002025. Link: https://goo.gl/mYJ1a6
  20. Krupitsky E, Nunes EV, Ling W, Gastfriend DR, Memisoglu A, et al. (2013) Injectable extended‐release naltrexone (XR‐NTX) for opioid dependence: long‐term safety and effectiveness. Addiction 108: 1628-1637. Link: https://goo.gl/QupUXD
  21. Ringwalt C, Gugelmann H, Garrettson M, Dasgupta N, Chung AE, et al. (2014) Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses. Pain Research and Management 19: 179-185. Link: https://goo.gl/RqaHJ0
  22. Barnett ML, Olenski AR, Jena AB (2017) Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use. New England Journal of Medicine 376: 663-673. Link: https://goo.gl/2SN8qy
  23. Deyo RA, Smith DH, Johnson ES, Donovan M, Tillotson CJ, et al. (2011) Opioids for back pain patients: primary care prescribing patterns and use of services. The Journal of the American Board of Family Medicine 24: 717-727. Link: https://goo.gl/ef3PSd
  24. Herzig SJ, Rothberg MB, Cheung M, Ngo LH, Marcantonio ER (2014) Opioid utilization and opioid‐related adverse events in nonsurgical patients in US hospitals. Journal of Hospital Medicine 9: 73-81. Link: https://goo.gl/uuvEmS
  25. Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, et al. (2015) Trends in opioid analgesic abuse and mortality in the United States. New England Journal of Medicine 372: 241-248. Link: https://goo.gl/rja9va
  26. Results from the 2012 National Survey on Drug Use and Health (2013) Summary of National Findings and Detailed Tables. Substance Abuse and Mental Health Services Administration. Link: https://goo.gl/Rh6Mhl
  27. Prescription Painkillers Overdoses (2013) Centers for Disease Control and Prevention. Link: https://goo.gl/cMU13M
  28. Bateman BT, Hernandez-Diaz S, Rathmell JP, Seeger JD, Doherty M, et al. (2014) Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology 120: 1216-1224. Link: https://goo.gl/czMkua
  29. Kuehn BM (2007) Opioid prescriptions soar. The Journal of American Medical Association 297: 249-251. Link: https://goo.gl/XGQa2A
  30. Compton WM, Jones CM, Baldwin GT (2016) Relationship between nonmedical prescription-opioid use and heroin use. New England Journal of Medicine 374: 154-163. Link: https://goo.gl/xpemY5
  31. Muhuri PK, Gfroerer JC, Davies MC (2013) Associations of nonmedical pain reliever use and initiation of heroin use in the United States. Center for Behavioral Health Statistics and Quality Data Review 17. Link: https://goo.gl/UOcyNz
  32. Krausz M, Degkwitz P, Haasen C, Verthein U (1996) Opioid addiction and suicidality. Crisis 17: 175-181. Link: https://goo.gl/49KKwH
  33. Bohnert AS, Ilgen MA, Galea S, McCarthy JF, Blow FC (2011) Accidental poisoning mortality among patients in the Department of Veterans Affairs Health System. Medical Care 49: 393-396. Link: https://goo.gl/fjhblH
  34. Childress S (2016) Veterans Face Greater Risks amid Opioid Crisis. FRONTLINE. Link: https://goo.gl/6JGMY7
  35. Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF (2016) Opioid prescribing after nonfatal overdose and association with repeated overdose: a cohort study. Annals of Internal Medicine 164: 1-9. Link: https://goo.gl/mWdQ4x
  36. Glauser W (2013) Pharma influence widespread at medical schools: study. Canadian Medical Association Journal 185: 1121-1122. Link: https://goo.gl/hSIVUY
  37. Baucus (2012) Grassley Seek Answers about Opioid Manufacturers' Ties to Medical Groups. United States Senate Committee on Finance. Link: https://goo.gl/2FxHpl
  38. Cassels A (2016) The Opioid Crisis: Facts that news coverage is missing. Health News Review. Link: https://goo.gl/kyx3JW
  39. McGinty EE, Kennedy-Hendricks A, Baller J, Niederdeppe J, Gollust S, et al. (2016) Criminal Activity or Treatable Health Condition? News Media Framing of Opioid Analgesic Abuse in the United States, 1998-2012. Psychiatric Services 67: 405-411. Link: https://goo.gl/HvSVme
  40. Dowell D, Haegerich TM, Chou R (2016) CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. The Journal of the American Medical Association 315: 1624-1645. Link: https://goo.gl/q72BIm
© 2017 Sarai SK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.